Literature DB >> 19396824

A CDKL5 mutated child with precocious puberty.

Veronica Saletti1, Laura Canafoglia, Paola Cambiaso, Silvia Russo, Margherita Marchi, Daria Riva.   

Abstract

To date, 43 patients have been described with mutations in or involving the CDKL5 gene. The typical phenotype includes early-onset, often intractable epileptic seizures and severe mental retardation with very limited progress in psychomotor development. Most patients also show impaired social interaction with avoidance of eye-to-eye contact, and some clinical features reminiscent of Rett syndrome (RTT), including stereotypic hand movements, lack of purposeful hand use, acquired microcephaly, and generalized hypotonia. We report on the case of a 5-year-old girl with a de novo CDKL5 gene mutation who developed early puberty, which has not been described before.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396824     DOI: 10.1002/ajmg.a.32806

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain.

Authors:  Sarah L Williamson; Laura Giudici; Charlotte Kilstrup-Nielsen; Wendy Gold; Gregory J Pelka; Patrick P L Tam; Andrew Grimm; Dionigio Prodi; Nicoletta Landsberger; John Christodoulou
Journal:  Hum Genet       Date:  2011-07-12       Impact factor: 4.132

2.  International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

Authors:  Sam Amin; Marie Monaghan; Angel Aledo-Serrano; Nadia Bahi-Buisson; Richard F Chin; Angus J Clarke; J Helen Cross; Scott Demarest; Orrin Devinsky; Jenny Downs; Elia M Pestana Knight; Heather Olson; Carol-Anne Partridge; Graham Stuart; Marina Trivisano; Sameer Zuberi; Tim A Benke
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

Review 3.  What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy.

Authors:  Charlotte Kilstrup-Nielsen; Laura Rusconi; Paolo La Montanara; Dalila Ciceri; Anna Bergo; Francesco Bedogni; Nicoletta Landsberger
Journal:  Neural Plast       Date:  2012-06-17       Impact factor: 3.599

4.  Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase.

Authors:  Ivan M Muñoz; Michael E Morgan; Julien Peltier; Florian Weiland; Mateusz Gregorczyk; Fiona Cm Brown; Thomas Macartney; Rachel Toth; Matthias Trost; John Rouse
Journal:  EMBO J       Date:  2018-09-28       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.